{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T05:40:42Z","timestamp":1794721242499,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Management after severe traumatic brain injury (TBI) aims to prevent secondary injury by optimizing cerebral physiology, yet conventional metrics such as intracranial pressure (ICP) and cerebral perfusion pressure (CPP) incompletely capture the underlying pathophysiology. Impaired cerebral pressure autoregulation (CPA) is common and may exacerbate secondary injury. Proteomic blood-based biomarkers (PBBMs) of astrocytic (glial fibrillary acidic protein [GFAP], S100 calcium-binding protein B [S100B]), and neuronal\/axonal injury (total tubulin associated unit [t-Tau], neurofilament light chain [NfL], ubiquitin C-terminal hydrolase-L1 [UCH-L1], neuron-specific enolase [NSE]) may provide global indicators of secondary injury. This study investigated temporal associations between PBBMs and cerebral physiological variables (ICP, CPP, pressure reactivity index [PRx], and CPP deviation from \u201coptimal\u201d CPP [\u0394CPPopt]), and evaluated the PBBMs as surrogate short-term endpoints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, observational multi-center study, used prospective data from the CENTER-TBI cohort and included 151 patients with high-frequency cerebral physiological data and serial PBBM measurements during the first seven days post-injury. Associations were analyzed using Spearman correlations, univariate and multivariate linear mixed effects models (LMEMs), as well as cross correlation analyses adjusted for repeated measures and clinical confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Elevated PBBM levels on day 1 were associated with a greater cumulative burden of high ICP, impaired CPA (positive PRx), and negative \u0394CPPopt over the subsequent seven days. Throughout the monitoring period, higher median PBBM concentrations correlated with elevated ICP and impaired CPA, with strongest associations when cerebral physiological monitoring and PBBMs were analyzed from the same day. In multivariate LMEMs, elevated ICP and most PBBMs remained significantly associated, while particularly PRx amplified this association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cerebral physiological disturbances during intensive care after TBI were associated with elevated PBBM levels, with ICP showing the strongest influence and impaired CPA amplifying some PBBM responses. Associations were strongest in same-day analyses and appeared bidirectional. These findings suggest that PBBM may reflect the burden of secondary cerebral insults and may serve as candidate endpoints for future trials targeting cerebral physiology, pending validation in prospective high-resolution studies. Importantly, our results highlight the potential for PBBMs to complement multimodal neuromonitoring by tracking secondary injury trajectories.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-026-06132-4","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:54:20Z","timestamp":1781351660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proteomic blood-based biomarkers of brain damage in traumatic brain injury: are they suitable surrogate endpoints for cerebral pressure autoregulatory-guided therapy?"],"prefix":"10.1186","volume":"30","author":[{"given":"Rozerin","family":"Kevci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"H\u00e5nell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Aries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"\u00c5kerlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Buki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhayu","family":"Bhattacharyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Di Tommaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Newcombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Lew\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Enblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erta","family":"Beqiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Smielewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodor Svedung","family":"Wettervik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the HR subgroup CENTER-TBI collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"6132_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bja\/aem131","volume":"99","author":"C Werner","year":"2007","unstructured":"Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth. 2007;99:4\u20139. https:\/\/doi.org\/10.1093\/bja\/aem131.","journal-title":"Br J Anaesth"},{"key":"6132_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/jnnp.2003.033126","volume":"75","author":"M Czosnyka","year":"2004","unstructured":"Czosnyka M, Pickard JD. Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry. 2004;75:813\u201321. https:\/\/doi.org\/10.1136\/jnnp.2003.033126.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6132_CR3","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1097\/CCM.0b013e3182514eb6","volume":"40","author":"MJH Aries","year":"2012","unstructured":"Aries MJH, Czosnyka M, Budohoski KP, Steiner LA, Lavinio A, Kolias AG, et al. Continuous determination of optimal cerebral perfusion pressure in traumatic brain injury. Crit Care Med. 2012;40:2456\u201363. https:\/\/doi.org\/10.1097\/CCM.0b013e3182514eb6.","journal-title":"Crit Care Med"},{"key":"6132_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s13054-023-04627-y","volume":"27","author":"T Svedung Wettervik","year":"2023","unstructured":"Svedung Wettervik T, Beqiri E, B\u00f6gli SY, Placek M, Guilfoyle MR, Helmy A, et al. Brain tissue oxygen monitoring in traumatic brain injury: part I-To what extent does PbtO2 reflect global cerebral physiology? Crit Care. 2023;27:339. https:\/\/doi.org\/10.1186\/s13054-023-04627-y.","journal-title":"Crit Care"},{"key":"6132_CR5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10877-023-01009-1","volume":"37","author":"E Beqiri","year":"2023","unstructured":"Beqiri E, Ercole A, Aries MJH, Placek MM, Tas J, Czosnyka M, et al. Towards autoregulation-oriented management after traumatic brain injury: increasing the reliability and stability of the CPPopt algorithm. J Clin Monit Comput. 2023;37:963\u201376. https:\/\/doi.org\/10.1007\/s10877-023-01009-1.","journal-title":"J Clin Monit Comput"},{"key":"6132_CR6","doi-asserted-by":"publisher","first-page":"e030727","DOI":"10.1136\/bmjopen-2019-030727","volume":"9","author":"E Beqiri","year":"2019","unstructured":"Beqiri E, Smielewski P, Robba C, Czosnyka M, Cabeleira MT, Tas J, et al. Feasibility of individualised severe traumatic brain injury management using an automated assessment of optimal cerebral perfusion pressure: the COGiTATE phase II study protocol. BMJ Open. 2019;9:e030727. https:\/\/doi.org\/10.1136\/bmjopen-2019-030727.","journal-title":"BMJ Open"},{"key":"6132_CR7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3171\/2014.3.JNS131500","volume":"120","author":"B Depreitere","year":"2014","unstructured":"Depreitere B, G\u00fciza F, Van den Berghe G, Schuhmann MU, Maier G, Piper I, et al. Pressure autoregulation monitoring and cerebral perfusion pressure target recommendation in patients with severe traumatic brain injury based on minute-by-minute monitoring data. J Neurosurg. 2014;120:1451\u20137. https:\/\/doi.org\/10.3171\/2014.3.JNS131500.","journal-title":"J Neurosurg"},{"key":"6132_CR8","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1089\/neu.2021.0197","volume":"38","author":"J Tas","year":"2021","unstructured":"Tas J, Beqiri E, van Kaam RC, Czosnyka M, Donnelly J, Haeren RH, et al. Targeting Autoregulation-Guided Cerebral Perfusion Pressure after Traumatic Brain Injury (COGiTATE): A Feasibility Randomized Controlled Clinical Trial. J Neurotrauma. 2021;38:2790\u2013800. https:\/\/doi.org\/10.1089\/neu.2021.0197.","journal-title":"J Neurotrauma"},{"key":"6132_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12028-023-01896-x","volume":"41","author":"A Prasad","year":"2024","unstructured":"Prasad A, Gilmore EJ, Kim JA, Begunova L, Olexa M, Beekman R, et al. Impact of Therapeutic Interventions on Cerebral Autoregulatory Function Following Severe Traumatic Brain Injury: A Secondary Analysis of the BOOST-II Study. Neurocrit Care. 2024;41:91\u20139. https:\/\/doi.org\/10.1007\/s12028-023-01896-x.","journal-title":"Neurocrit Care"},{"key":"6132_CR10","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S1474-4422(22)00218-6","volume":"21","author":"IRAR Helmrich","year":"2022","unstructured":"Helmrich IRAR, Czeiter E, Amrein K, B\u00fcki A, Lingsma HF, Menon DK, et al. Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort study. Lancet Neurol. 2022;21:792\u2013802. https:\/\/doi.org\/10.1016\/S1474-4422(22)00218-6.","journal-title":"Lancet Neurol"},{"key":"6132_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1474-4422(22)00256-3","volume":"21","author":"FK Korley","year":"2022","unstructured":"Korley FK, Jain S, Sun X, Puccio AM, Yue JK, Gardner RC, et al. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study. Lancet Neurol. 2022;21:803\u201313. https:\/\/doi.org\/10.1016\/S1474-4422(22)00256-3.","journal-title":"Lancet Neurol"},{"key":"6132_CR12","doi-asserted-by":"publisher","first-page":"R156","DOI":"10.1186\/cc10286","volume":"15","author":"S Mondello","year":"2011","unstructured":"Mondello S, Papa L, Buki A, Bullock MR, Czeiter E, Tortella FC, et al. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit Care. 2011;15:R156. https:\/\/doi.org\/10.1186\/cc10286.","journal-title":"Crit Care"},{"key":"6132_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3171\/2022.5.JNS22638","volume":"138","author":"AM Casta\u00f1o-Leon","year":"2023","unstructured":"Casta\u00f1o-Leon AM, S\u00e1nchez Carabias C, Hilario A, Ramos A, Navarro-Main B, Paredes I, et al. Serum assessment of traumatic axonal injury: the correlation of GFAP, t-Tau, UCH-L1, and NfL levels with diffusion tensor imaging metrics and its prognosis utility. J Neurosurg. 2023;138:454\u201364. https:\/\/doi.org\/10.3171\/2022.5.JNS22638.","journal-title":"J Neurosurg"},{"key":"6132_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/CCM.0b013e3181b788ab","volume":"38","author":"L Papa","year":"2010","unstructured":"Papa L, Akinyi L, Liu MC, Pineda JA, Tepas JJ, Oli MW, et al. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit Care Med. 2010;38:138\u201344. https:\/\/doi.org\/10.1097\/CCM.0b013e3181b788ab.","journal-title":"Crit Care Med"},{"key":"6132_CR15","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1002\/ams2.622","volume":"8","author":"KKW Wang","year":"2021","unstructured":"Wang KKW, Kobeissy FH, Shakkour Z, Tyndall JA. Thorough overview of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury. Acute Med Surg. 2021;8:e622. https:\/\/doi.org\/10.1002\/ams2.622.","journal-title":"Acute Med Surg"},{"key":"6132_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13054-016-1450-y","volume":"20","author":"EP Thelin","year":"2016","unstructured":"Thelin EP, Jeppsson E, Frostell A, Svensson M, Mondello S, Bellander B-M, et al. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity. Crit Care. 2016;20:285. https:\/\/doi.org\/10.1186\/s13054-016-1450-y.","journal-title":"Crit Care"},{"key":"6132_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1089\/neu.2012.2553","volume":"30","author":"EP Thelin","year":"2013","unstructured":"Thelin EP, Johannesson L, Nelson D, Bellander B-M. S100B is an important outcome predictor in traumatic brain injury. J Neurotrauma. 2013;30:519\u201328. https:\/\/doi.org\/10.1089\/neu.2012.2553.","journal-title":"J Neurotrauma"},{"key":"6132_CR18","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1089\/neu.2019.6375","volume":"36","author":"E Thelin","year":"2019","unstructured":"Thelin E, Al Nimer F, Frostell A, Zetterberg H, Blennow K, Nystr\u00f6m H, et al. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury. J Neurotrauma. 2019;36:2850\u201362. https:\/\/doi.org\/10.1089\/neu.2019.6375.","journal-title":"J Neurotrauma"},{"key":"6132_CR19","doi-asserted-by":"publisher","first-page":"105298","DOI":"10.1016\/j.ebiom.2024.105298","volume":"107","author":"L Wilson","year":"2024","unstructured":"Wilson L, Newcombe VFJ, Whitehouse DP, Mondello S, Maas AIR, Menon DK, et al. Association of early blood-based biomarkers and six-month functional outcomes in conventional severity categories of traumatic brain injury: capturing the continuous spectrum of injury. EBioMedicine. 2024;107:105298. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105298.","journal-title":"EBioMedicine"},{"key":"6132_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1474-4422(23)00358-7","volume":"23","author":"CAI \u00c5kerlund","year":"2024","unstructured":"\u00c5kerlund CAI, Holst A, Bhattacharyay S, Stocchetti N, Steyerberg E, Smielewski P, et al. Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study. Lancet Neurol. 2024;23:71\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(23)00358-7.","journal-title":"Lancet Neurol"},{"key":"6132_CR21","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1002\/alz.13898","volume":"20","author":"P Shahim","year":"2024","unstructured":"Shahim P, Pham DL, van der Merwe AJ, Moore B, Chou Y-Y, Lippa SM, et al. Serum NfL and GFAP as biomarkers of progressive neurodegeneration in TBI. Alzheimers Dement. 2024;20:4663\u201376. https:\/\/doi.org\/10.1002\/alz.13898.","journal-title":"Alzheimers Dement"},{"key":"6132_CR22","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1089\/neu.2024.0581","volume":"42","author":"JJ Bazarian","year":"2025","unstructured":"Bazarian JJ, Zetterberg H, Buki A, Dengler BA, Diaz-Arrastia R, Korley FK, et al. Blood-Based Biomarkers for Improved Characterization of Traumatic Brain Injury: Recommendations from the 2024 National Institute for Neurological Disorders and Stroke Traumatic Brain Injury Classification and Nomenclature Initiative Blood-Based Biomarkers Working Group. J Neurotrauma. 2025;42:1065\u201385. https:\/\/doi.org\/10.1089\/neu.2024.0581.","journal-title":"J Neurotrauma"},{"key":"6132_CR23","doi-asserted-by":"publisher","first-page":"e0132177","DOI":"10.1371\/journal.pone.0132177","volume":"10","author":"F Al Nimer","year":"2015","unstructured":"Al Nimer F, Thelin E, Nystr\u00f6m H, Dring AM, Svenningsson A, Piehl F, et al. Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light. PLoS ONE. 2015;10:e0132177. https:\/\/doi.org\/10.1371\/journal.pone.0132177.","journal-title":"PLoS ONE"},{"key":"6132_CR24","doi-asserted-by":"publisher","first-page":"36791","DOI":"10.1038\/srep36791","volume":"6","author":"P Shahim","year":"2016","unstructured":"Shahim P, Gren M, Liman V, Andreasson U, Norgren N, Tegner Y, et al. Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Sci Rep. 2016;6:36791. https:\/\/doi.org\/10.1038\/srep36791.","journal-title":"Sci Rep"},{"key":"6132_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fneur.2017.00300","volume":"8","author":"EP Thelin","year":"2017","unstructured":"Thelin EP, Zeiler FA, Ercole A, Mondello S, B\u00fcki A, Bellander B-M, et al. Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review. Front Neurol. 2017;8:300. https:\/\/doi.org\/10.3389\/fneur.2017.00300.","journal-title":"Front Neurol"},{"key":"6132_CR26","doi-asserted-by":"publisher","first-page":"103777","DOI":"10.1016\/j.ebiom.2021.103777","volume":"75","author":"DP Whitehouse","year":"2022","unstructured":"Whitehouse DP, Monteiro M, Czeiter E, Vyvere TV, Valerio F, Ye Z, et al. Relationship of admission blood proteomic biomarkers levels to lesion type and lesion burden in traumatic brain injury: A CENTER-TBI study. EBioMedicine. 2022;75:103777. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103777.","journal-title":"EBioMedicine"},{"key":"6132_CR27","doi-asserted-by":"publisher","first-page":"102785","DOI":"10.1016\/j.ebiom.2020.102785","volume":"56","author":"E Czeiter","year":"2020","unstructured":"Czeiter E, Amrein K, Gravesteijn BY, Lecky F, Menon DK, Mondello S, et al. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study. EBioMedicine. 2020;56:102785. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102785.","journal-title":"EBioMedicine"},{"key":"6132_CR28","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","volume":"54","author":"J Kuhle","year":"2016","unstructured":"Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius \u00c5, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med. 2016;54:1655\u201361. https:\/\/doi.org\/10.1515\/cclm-2015-1195.","journal-title":"Clin Chem Lab Med"},{"key":"6132_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-51123-8","author":"J-M Galarneau","year":"2026","unstructured":"Galarneau J-M, Tabor JB, Bodnar T, Josafatow-Garc\u00eda NO, Yeates KO, Wellington CL, et al. Simoa and MSD platforms show analytical discordance but comparable diagnostic performance for GFAP, NF-L, and T-tau in adolescent concussion. Sci Rep. 2026. https:\/\/doi.org\/10.1038\/s41598-026-51123-8.","journal-title":"Sci Rep"},{"key":"6132_CR30","doi-asserted-by":"publisher","first-page":"379071","DOI":"10.1155\/2015\/379071","volume":"2015","author":"L Hajdukov\u00e1","year":"2015","unstructured":"Hajdukov\u00e1 L, Sobek O, Prchalov\u00e1 D, B\u00edlkov\u00e1 Z, Koudelkov\u00e1 M, Luk\u00e1\u0161kov\u00e1 J, et al. Biomarkers of Brain Damage: S100B and NSE Concentrations in Cerebrospinal Fluid\u2013A Normative Study. Biomed Res Int. 2015;2015:379071. https:\/\/doi.org\/10.1155\/2015\/379071.","journal-title":"Biomed Res Int"},{"key":"6132_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C, Ullman JS, Hawryluk GWJ, Bell MJ, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery. 2017;80:6\u201315. https:\/\/doi.org\/10.1227\/NEU.0000000000001432.","journal-title":"Neurosurgery"},{"key":"6132_CR32","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1089\/neu.2019.6808","volume":"37","author":"FA Zeiler","year":"2020","unstructured":"Zeiler FA, Ercole A, Beqiri E, Cabeleira M, Thelin EP, Stocchetti N, et al. Association between Cerebrovascular Reactivity Monitoring and Mortality Is Preserved When Adjusting for Baseline Admission Characteristics in Adult Traumatic Brain Injury: A CENTER-TBI Study. J Neurotrauma. 2020;37:1233\u201341. https:\/\/doi.org\/10.1089\/neu.2019.6808.","journal-title":"J Neurotrauma"},{"key":"6132_CR33","doi-asserted-by":"publisher","first-page":"102835","DOI":"10.1016\/j.bas.2024.102835","volume":"4","author":"P Smielewski","year":"2024","unstructured":"Smielewski P, Beqiri E, Mataczynski C, Placek M, Kazimierska A, Hutchinson PJ, et al. Advanced neuromonitoring powered by ICM\u2009+\u2009and its place in the Brand New AI World, reflections at the 20th anniversary boundary. Brain Spine. 2024;4:102835. https:\/\/doi.org\/10.1016\/j.bas.2024.102835.","journal-title":"Brain Spine"},{"key":"6132_CR34","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1089\/neu.2019.6814","volume":"37","author":"F Mathieu","year":"2020","unstructured":"Mathieu F, Zeiler FA, Ercole A, Monteiro M, Kamnitsas K, Glocker B, et al. Relationship between Measures of Cerebrovascular Reactivity and Intracranial Lesion Progression in Acute Traumatic Brain Injury Patients: A CENTER-TBI Study. J Neurotrauma. 2020;37:1556\u201365. https:\/\/doi.org\/10.1089\/neu.2019.6814.","journal-title":"J Neurotrauma"},{"key":"6132_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00006123-199707000-00005","volume":"41","author":"M Czosnyka","year":"1997","unstructured":"Czosnyka M, Smielewski P, Kirkpatrick P, Laing RJ, Menon D, Pickard JD. Continuous assessment of the cerebral vasomotor reactivity in head injury. Neurosurgery. 1997;41:11\u20137. https:\/\/doi.org\/10.1097\/00006123-199707000-00005. discussion 17\u201319.","journal-title":"Neurosurgery"},{"key":"6132_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-030-59436-7_34","volume":"131","author":"A Liberti","year":"2021","unstructured":"Liberti A, Beqiri E, Ercole A, Cabeleira M, Tas J, Zeiler FA, et al. Patient\u2019s Clinical Presentation and CPPopt Availability. Any Association? Acta Neurochir Suppl. 2021;131:167\u201372. https:\/\/doi.org\/10.1007\/978-3-030-59436-7_34.","journal-title":"Any Association? Acta Neurochir Suppl"},{"key":"6132_CR37","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1097\/CCM.0000000000002575","volume":"45","author":"J Donnelly","year":"2017","unstructured":"Donnelly J, Czosnyka M, Adams H, Robba C, Steiner LA, Cardim D, et al. Individualizing Thresholds of Cerebral Perfusion Pressure Using Estimated Limits of Autoregulation. Crit Care Med. 2017;45:1464\u201371. https:\/\/doi.org\/10.1097\/CCM.0000000000002575.","journal-title":"Crit Care Med"},{"key":"6132_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13054-023-04485-8","volume":"27","author":"E Beqiri","year":"2023","unstructured":"Beqiri E, Zeiler FA, Ercole A, Placek MM, Tas J, Donnelly J, et al. The lower limit of reactivity as a potential individualised cerebral perfusion pressure target in traumatic brain injury: a CENTER-TBI high-resolution sub-study analysis. Crit Care. 2023;27:194. https:\/\/doi.org\/10.1186\/s13054-023-04485-8.","journal-title":"Crit Care"},{"key":"6132_CR39","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/neu.1998.15.587","volume":"15","author":"GM Teasdale","year":"1998","unstructured":"Teasdale GM, Pettigrew LE, Wilson JT, Murray G, Jennett B. Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. J Neurotrauma. 1998;15:587\u201397. https:\/\/doi.org\/10.1089\/neu.1998.15.587.","journal-title":"J Neurotrauma"},{"key":"6132_CR40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/neu.1998.15.573","volume":"15","author":"JT Wilson","year":"1998","unstructured":"Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15:573\u201385. https:\/\/doi.org\/10.1089\/neu.1998.15.573.","journal-title":"J Neurotrauma"},{"key":"6132_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/08977151251384988","author":"R Kevci","year":"2025","unstructured":"Kevci R, H\u00e5nell A, Lew\u00e9n A, Enblad P, Bhattacharyay S, Di Tommaso G, et al. Visualizations of Autoregulatory Insults in Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research-Traumatic Brain Injury Cohort Study. J Neurotrauma. 2025. https:\/\/doi.org\/10.1177\/08977151251384988.","journal-title":"J Neurotrauma"},{"key":"6132_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/s0006-8993(02)02920-7","volume":"947","author":"FP Zemlan","year":"2002","unstructured":"Zemlan FP, Jauch EC, Mulchahey JJ, Gabbita SP, Rosenberg WS, Speciale SG, et al. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 2002;947:131\u20139. https:\/\/doi.org\/10.1016\/s0006-8993(02)02920-7.","journal-title":"Brain Res"},{"key":"6132_CR43","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S1474-4422(25)00154-1","volume":"24","author":"GT Manley","year":"2025","unstructured":"Manley GT, Dams-O\u2019Connor K, Alosco ML, Awwad HO, Bazarian JJ, Bragge P, et al. A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature Initiative. Lancet Neurol. 2025;24:512\u201323. https:\/\/doi.org\/10.1016\/S1474-4422(25)00154-1.","journal-title":"Lancet Neurol"},{"key":"6132_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/diagnostics6040037","volume":"6","author":"T Bogoslovsky","year":"2016","unstructured":"Bogoslovsky T, Gill J, Jeromin A, Davis C, Diaz-Arrastia R. Fluid Biomarkers of Traumatic Brain Injury and Intended Context of Use. Diagnostics (Basel). 2016;6:37. https:\/\/doi.org\/10.3390\/diagnostics6040037.","journal-title":"Diagnostics (Basel)"},{"key":"6132_CR45","doi-asserted-by":"publisher","first-page":"fcag055","DOI":"10.1093\/braincomms\/fcag055","volume":"8","author":"TS Do","year":"2026","unstructured":"Do TS, Carnes C, Yang Z, Kobeissy F, Yadikar H, Olbricht G, et al. Serum biomarker trajectory clusters predict functional outcome and quality of life for traumatic brain injury. Brain Commun. 2026;8:fcag055. https:\/\/doi.org\/10.1093\/braincomms\/fcag055.","journal-title":"Brain Commun"},{"key":"6132_CR46","unstructured":"Pinto VL, Adeyinka A. Oct. Increased Intracranial Pressure. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Oct 5]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482119\/. Accessed 5 2025."},{"key":"6132_CR47","unstructured":"Le Roux P. Intracranial Pressure Monitoring and Management. In: Laskowitz D, Grant G, editorsOct. Translational Research in Traumatic Brain Injury [Internet]. Boca Raton (FL): CRC Press\/Taylor and Francis Group; 2016 [cited 2025 Oct 5]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326713\/. Accessed 5 2025."},{"key":"6132_CR48","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/jcbfm.2012.95","volume":"32","author":"AD Lafrenaye","year":"2012","unstructured":"Lafrenaye AD, McGinn MJ, Povlishock JT. Increased intracranial pressure after diffuse traumatic brain injury exacerbates neuronal somatic membrane poration but not axonal injury: evidence for primary intracranial pressure-induced neuronal perturbation. J Cereb Blood Flow Metab. 2012;32:1919\u201332. https:\/\/doi.org\/10.1038\/jcbfm.2012.95.","journal-title":"J Cereb Blood Flow Metab"},{"key":"6132_CR49","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/CCM.0000000000006287","volume":"52","author":"T Svedung Wettervik","year":"2024","unstructured":"Svedung Wettervik T, Beqiri E, H\u00e5nell A, B\u00f6gli SY, Placek M, Donnelly J, et al. Visualization of Cerebral Pressure Autoregulatory Insults in Traumatic Brain Injury. Crit Care Med. 2024;52:1228\u201338. https:\/\/doi.org\/10.1097\/CCM.0000000000006287.","journal-title":"Crit Care Med"},{"key":"6132_CR50","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1089\/neu.2018.6157","volume":"36","author":"T Svedung Wettervik","year":"2019","unstructured":"Svedung Wettervik T, Howells T, Enblad P, Lew\u00e9n A. Temporal Neurophysiological Dynamics in Traumatic Brain Injury: Role of Pressure Reactivity and Optimal Cerebral Perfusion Pressure for Predicting Outcome. J Neurotrauma. 2019;36:1818\u201327. https:\/\/doi.org\/10.1089\/neu.2018.6157.","journal-title":"J Neurotrauma"},{"key":"6132_CR51","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13054-025-05458-9","volume":"29","author":"SY B\u00f6gli","year":"2025","unstructured":"B\u00f6gli SY, Olakorede I, Beqiri E, Chen X, Lavinio A, Hutchinson P, et al. Cerebral perfusion pressure targets after traumatic brain injury: a reappraisal. Crit Care. 2025;29:207. https:\/\/doi.org\/10.1186\/s13054-025-05458-9.","journal-title":"Crit Care"},{"key":"6132_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12028-012-9687-z","volume":"17","author":"MJH Aries","year":"2012","unstructured":"Aries MJH, Czosnyka M, Budohoski KP, Kolias AG, Radolovich DK, Lavinio A, et al. Continuous monitoring of cerebrovascular reactivity using pulse waveform of intracranial pressure. Neurocrit Care. 2012;17:67\u201376. https:\/\/doi.org\/10.1007\/s12028-012-9687-z.","journal-title":"Neurocrit Care"},{"key":"6132_CR53","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1515\/CCLM.2006.218","volume":"44","author":"AB da Rocha","year":"2006","unstructured":"da Rocha AB, Schneider RF, de Freitas GR, Andr\u00e9 C, Grivicich I, Zanoni C, et al. Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males. Clin Chem Lab Med. 2006;44:1234\u201342. https:\/\/doi.org\/10.1515\/CCLM.2006.218.","journal-title":"Clin Chem Lab Med"},{"key":"6132_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00701-016-3046-3","volume":"159","author":"EP Thelin","year":"2017","unstructured":"Thelin EP, Nelson DW, Bellander B-M. A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Acta Neurochir (Wien). 2017;159:209\u201325. https:\/\/doi.org\/10.1007\/s00701-016-3046-3.","journal-title":"Acta Neurochir (Wien)"},{"key":"6132_CR55","doi-asserted-by":"publisher","unstructured":"Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med. 1996;125:605\u201313. https:\/\/doi.org\/10.7326\/0003-4819-125-7-199610010-00011.","DOI":"10.7326\/0003-4819-125-7-199610010-00011"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06132-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06132-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06132-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:27:22Z","timestamp":1781515642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06132-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6132"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06132-4","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained for each recruiting site. The list of sites, Ethical Committees, approval numbers and approval dates can be found on the website:\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ICM+ is a software licensed by Cambridge Enterprise Ltd. PS has a financial interest in a part of licensing fee; the licensing fee was waivered for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"311"}}